Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes

NCT01758471 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Glipizide
DRUG: Acarbose

Sponsor

Shanghai Jiao Tong University School of Medicine